RJA
MDAS

Raymond James & Associates’s MEDASSETS INC COM STK (DE) MDAS Stock Holding History

Raymond James & Associates’s Portfolio MDAS Stock Details MDAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-16,184
Closed -$501K – 3016
2015
Q4 		$501K Buy
16,184
+972
+6% +$27K ﹤0.01% 1984
2015
Q3 		$305K Sell
15,212
-8
-0.1% -$170 ﹤0.01% 2126
2015
Q2 		$336K Buy
15,220
+129
+0.9% +$2.69K ﹤0.01% 2245
2015
Q1 		$284K Sell
15,091
-414
-3% -$7.88K ﹤0.01% 2233
2014
Q4 		$306K Buy
+15,505
New +$315K ﹤0.01% 2127

Raymond James & Associates's MDAS Position: Q1 2016 in Review

Raymond James & Associates sold out of MEDASSETS INC COM STK (DE) (MDAS) in Q1 2016, closing a stake of 16,184 shares — an estimated $501K sold.

Raymond James & Associates first reported a position in MDAS in Q4 2014 and held it in 5 quarters. The position peaked at $501K in Q4 2015. 0 funds tracked by Wall St. Rank hold MDAS as of Q1 2016.

  • Raymond James & Associates reported no remaining MEDASSETS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Raymond James & Associates sold 16,184 MEDASSETS INC COM STK (DE) shares in Q1 2016, an estimated $501K.
  • Raymond James & Associates first reported a position in MEDASSETS INC COM STK (DE) in Q4 2014 and held it in 5 quarters.
  • Raymond James & Associates's MEDASSETS INC COM STK (DE) position peaked at $501K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held MEDASSETS INC COM STK (DE) as of Q1 2016.

Based on Raymond James & Associates's 13F filing for Q1 2016, filed 12 May 2016.